Dr. Khariton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 S 31st St
Temple, TX 76508Phone+1 254-724-2111
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2013 - 2016
- University of Missouri Kansas City School of MedicineClass of 2013
Certifications & Licensure
- TX State Medical License 2022 - 2025
- MO State Medical License 2016 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 4 citationsAssociation Between Change in Ambulatory Pulmonary Artery Pressures and Natriuretic Peptides in Patients with Heart Failure: Results From the EMBRACE-HF Trial.Michael E Nassif, Dan Nguyen, John A Spertus, Kensey L Gosch, Fengming Tang
Journal of Cardiac Failure. 2023-09-01 - Update on cardiogenic shock: from detection to team management.Yevgeniy Khariton, Ossama Abou Hassan, Jaime A Hernandez-Montfort
Current Opinion in Cardiology. 2023-03-01 - 302 citationsThe SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug, Dalane W. Kitzman, Sanjiv J. Shah
Nature Medicine. 2021-10-28
Press Mentions
- Sacubitril/valsartan Improves Short-Term Health Outcomes in Those with HFrEFNovember 1st, 2019
- Advanced Heart Failure Therapies for Hypertrophic Cardiomyopathy: State-of-the-Art Review and an Updated Analysis from UNOS (JACC Heart Failure November 2023)November 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: